The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Peptide Research Overview Mechanisms, Applications & Insights Two new treatments, now available Copper Peptide Skin Complex brings prescription grade GHK Cu Acetate to support skin repair and renewal at the cellular level. Lash Growth Serum combines bimatoprost and latanoprost, prescription strength The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure